Inogen is a global leader in the production of portable oxygen concentrators (POCs). These devices are utilised by patients requiring long-term oxygen therapy for conditions such as chronic obstructive pulmonary disease (COPD). Unlike large, stationary oxygen tanks that restrict mobility, POCs enable patients to remain mobile while receiving therapy. Inogen’s POCs can operate for up to 13 hours and weigh just over two kilograms, offering both convenience and extended functionality.

The company distributes its products through multiple channels, including direct-to-consumer sales (typically on a private pay basis), rental agreements, and through home care distributors in the United States and international markets.

Inogen’s primary manufacturing facility is located in Texas, with additional manufacturing operations in California and the Czech Republic, supporting its global supply chain and distribution network.